Subscribe To
Why wolfspeed stock soared more than 25% higher today
Wolfspeed's shares surged after a better-than-expected Q1 earnings report with soft sales but also limited bottom-line losses. The stock had been down...
October 31, 2023, 12:26 pm
Altria won't make you a millionaire; still a great buy
Altria's stock has not performed as well as expected, but still offers good returns for income investor...
October 31, 2023, 12:25 pm
Eurusd technical analysis
EURUSD Fundamental Analysis USThe Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher,...
October 31, 2023, 11:46 am
10 years of midstream: total return still compelling
Summary Energy infrastructure ETFs that include corporations and MLPs tend to be appealing for their total return potential, while providing better re...
October 31, 2023, 11:28 am
Audusd technical analysis
AUDUSD Fundamental Analysis USThe Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher,...
October 31, 2023, 10:36 am
Potbelly (pbpb) is attractively priced despite fast-paced momentum
Potbelly (PBPB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are s...
October 31, 2023, 10:32 am
Skywest (skyw) is attractively priced despite fast-paced momentum
SkyWest (SKYW) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are s...
October 31, 2023, 10:32 am
Uaw strikes cost stellantis about $3.2 billion in revenue
Stellantis has announced tentative agreements with both the UAW and Canadian Unifor unions since Saturday, however the deals must s...
October 31, 2023, 10:12 am
Pfizer's coming for abbvie's market share. here's what it means for investors
Pfizer just got an approval for a drug to treat ulcerative colitis. AbbVie is still trying to consolida...
October 31, 2023, 10:07 am
Nzdusd technical analysis
NZDUSD Fundamental Analysis USThe Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher,...
October 31, 2023, 9:30 am
Gold demand weakens in q3 but still beats historical averages - world gold council
Global demand (excluding over-the-counter (OTC) purchases) fell 6% during the third quarter, to 1,147 tonnes....
October 31, 2023, 9:15 am
Up 70% this year, here's why it's still an excellent time to buy tesla stock
Tesla's stock has just dropped 20% in less than a month. Tesla has a brand new revenue stream emerging....
October 31, 2023, 8:27 am
Usdcad technical analysis - time for a deeper pullback
USDCAD Fundamental Analysis USThe Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher,...
October 31, 2023, 8:19 am
Is apple stock still a buy?
Earlier this month, analysts at KeyBanc Capital Markets downgraded Apple's (NASDAQ: AAPL) stock, citing near-all-time high valuation levels and an exp...
October 31, 2023, 7:52 am
Gbp/jpy daily outlook
Daily Pivots: (S1) 180.81; (P) 181.35; (R1) 181.92; More… GBP/JPY recovered quickly after dipping to 180.74. Intraday bias stays neutral and further...
October 31, 2023, 7:38 am
Eur/jpy daily outlook
Daily Pivots: (S1) 157.64; (P) 158.29; (R1) 158.87; More…. Intraday bias in EUR/JPY remains neutral as it’s s...
October 31, 2023, 7:36 am
Gbpusd technical analysis - the bearish bias is still intact
GBPUSD Fundamental Analysis USThe Fed left interest rates unchanged as expected at the last meeting.The macroeconomic projections were revised higher,...
October 31, 2023, 7:08 am
2 dazzling growth stocks you can buy now with less than $300
Tesla's Cybertruck is going to be a top seller, but the company still has a small share of total vehicl...
October 31, 2023, 6:20 am
Usd/jpy daily outlook
Daily Pivots: (S1) 148.63; (P) 149.24; (R1) 149.67; More… USD/JPY rebounded strongly despite dipping to 148.79. Intraday bias remains neutral at thi...
October 31, 2023, 5:26 am
Is abbvie still a good dividend stock to buy?
AbbVie's best-selling product lost patent-protected market exclusivity in the U.S. this year. Competition with lower-cost biosimilar versions of Humir...
October 31, 2023, 5:23 am